On the one hand, advances have been aimed at improving the effectiveness of MM vaccines based on the identification of various MM associated antigens (i.e., MAGE, GAGE, SPANXC, SSX, etc.)[33-40]. The gene discussed is SPANXC; the disease is Miyoshi myopathy.